Antibe Therapeutics Stock Market Value

ATBPF Stock  USD 0.22  0.00  0.00%   
Antibe Therapeutics' market value is the price at which a share of Antibe Therapeutics trades on a public exchange. It measures the collective expectations of Antibe Therapeutics investors about its performance. Antibe Therapeutics is trading at 0.22 as of the 5th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.22.
With this module, you can estimate the performance of a buy and hold strategy of Antibe Therapeutics and determine expected loss or profit from investing in Antibe Therapeutics over a given investment horizon. Check out Antibe Therapeutics Correlation, Antibe Therapeutics Volatility and Antibe Therapeutics Alpha and Beta module to complement your research on Antibe Therapeutics.
Symbol

Please note, there is a significant difference between Antibe Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Antibe Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Antibe Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Antibe Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Antibe Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Antibe Therapeutics.
0.00
11/05/2024
No Change 0.00  0.0 
In 31 days
12/05/2024
0.00
If you would invest  0.00  in Antibe Therapeutics on November 5, 2024 and sell it all today you would earn a total of 0.00 from holding Antibe Therapeutics or generate 0.0% return on investment in Antibe Therapeutics over 30 days. Antibe Therapeutics is related to or competes with Covalon Technologies, Mosaic Immunoengineerin, and Cellectis. Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the a... More

Antibe Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Antibe Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Antibe Therapeutics upside and downside potential and time the market with a certain degree of confidence.

Antibe Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Antibe Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Antibe Therapeutics' standard deviation. In reality, there are many statistical measures that can use Antibe Therapeutics historical prices to predict the future Antibe Therapeutics' volatility.
Hype
Prediction
LowEstimatedHigh
0.220.220.22
Details
Intrinsic
Valuation
LowRealHigh
0.180.180.24
Details
Naive
Forecast
LowNextHigh
0.220.220.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.220.220.22
Details

Antibe Therapeutics Backtested Returns

We have found three technical indicators for Antibe Therapeutics, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Antibe Therapeutics are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

Antibe Therapeutics has no correlation between past and present. Overlapping area represents the amount of predictability between Antibe Therapeutics time series from 5th of November 2024 to 20th of November 2024 and 20th of November 2024 to 5th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Antibe Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Antibe Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Antibe Therapeutics lagged returns against current returns

Autocorrelation, which is Antibe Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Antibe Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Antibe Therapeutics returns to help us make a trade decision. For example, suppose you find that Antibe Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Antibe Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Antibe Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Antibe Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Antibe Therapeutics pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Antibe Therapeutics Lagged Returns

When evaluating Antibe Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Antibe Therapeutics pink sheet have on its future price. Antibe Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Antibe Therapeutics autocorrelation shows the relationship between Antibe Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Antibe Therapeutics.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Antibe Pink Sheet

Antibe Therapeutics financial ratios help investors to determine whether Antibe Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Antibe with respect to the benefits of owning Antibe Therapeutics security.